CACCIOLA, Rossella Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 13.159
AS - Asia 6.488
EU - Europa 5.997
SA - Sud America 1.091
AF - Africa 460
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.213
Nazione #
US - Stati Uniti d'America 12.608
SG - Singapore 3.676
RU - Federazione Russa 1.705
CN - Cina 1.598
IE - Irlanda 1.178
UA - Ucraina 1.097
BR - Brasile 900
IT - Italia 775
CA - Canada 452
VN - Vietnam 424
FR - Francia 399
KR - Corea 192
DE - Germania 181
GB - Regno Unito 158
NG - Nigeria 152
IN - India 145
CI - Costa d'Avorio 119
SE - Svezia 116
BD - Bangladesh 81
AR - Argentina 69
NL - Olanda 61
PL - Polonia 59
MX - Messico 49
CH - Svizzera 44
IQ - Iraq 43
UZ - Uzbekistan 42
FI - Finlandia 41
ZA - Sudafrica 41
KE - Kenya 38
TR - Turchia 38
JP - Giappone 37
EC - Ecuador 32
ES - Italia 30
HK - Hong Kong 30
VE - Venezuela 26
PK - Pakistan 24
SN - Senegal 23
AT - Austria 22
CO - Colombia 21
ID - Indonesia 21
MA - Marocco 21
EG - Egitto 18
SA - Arabia Saudita 18
BE - Belgio 17
GR - Grecia 17
LB - Libano 15
LT - Lituania 15
RO - Romania 15
BG - Bulgaria 14
BJ - Benin 12
CL - Cile 12
CZ - Repubblica Ceca 11
IR - Iran 11
PH - Filippine 11
AE - Emirati Arabi Uniti 9
JO - Giordania 9
MY - Malesia 9
PE - Perù 9
TT - Trinidad e Tobago 9
AU - Australia 8
BY - Bielorussia 8
DZ - Algeria 8
ET - Etiopia 8
IL - Israele 8
PY - Paraguay 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
NP - Nepal 7
CR - Costa Rica 6
EU - Europa 6
KZ - Kazakistan 6
LY - Libia 6
NI - Nicaragua 6
PT - Portogallo 6
TN - Tunisia 6
UY - Uruguay 6
BO - Bolivia 5
AL - Albania 4
HR - Croazia 4
JM - Giamaica 4
KW - Kuwait 4
LV - Lettonia 4
AM - Armenia 3
DK - Danimarca 3
GY - Guiana 3
HN - Honduras 3
HU - Ungheria 3
OM - Oman 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
GT - Guatemala 2
NZ - Nuova Zelanda 2
PA - Panama 2
Totale 27.187
Città #
Dallas 2.280
Singapore 2.037
Dublin 1.174
Santa Clara 1.140
Jacksonville 1.054
Ashburn 1.039
Chandler 996
San Jose 964
Moscow 630
Boardman 484
Nanjing 364
Andover 320
Cambridge 317
Lawrence 316
Toronto 315
Lauterbourg 306
Chicago 226
Hefei 208
Los Angeles 205
San Mateo 197
Seoul 192
Des Moines 184
Beijing 155
Catania 153
Ho Chi Minh City 133
Wilmington 121
Abidjan 119
Nanchang 109
New York 103
Hanoi 93
Hebei 93
São Paulo 92
Council Bluffs 82
Lagos 82
Saint Petersburg 82
Shenyang 80
Civitanova Marche 75
Grafing 69
Buffalo 67
Jiaxing 67
Ottawa 66
Abuja 58
Changsha 55
Tianjin 53
Warsaw 47
Bari 45
Montreal 41
Orem 39
Milan 38
Tokyo 34
Phoenix 31
Seattle 31
Houston 30
Palermo 30
Rio de Janeiro 30
Atlanta 29
Brooklyn 29
Washington 28
Boston 27
Pune 27
San Francisco 27
Amsterdam 26
Dong Ket 26
London 26
Piscataway 26
Denver 25
Poplar 25
Hong Kong 24
Johannesburg 24
Redondo Beach 24
Dakar 23
Norwalk 23
Kunming 22
Augusta 21
Bremen 21
Den Haag 21
Stockholm 21
Da Nang 20
Munich 20
Baghdad 19
Liberty Lake 19
Tashkent 19
Helsinki 18
Belo Horizonte 17
Brussels 17
Curitiba 16
Mumbai 16
Hangzhou 15
Lappeenranta 15
The Dalles 15
Brasília 14
Chennai 14
Columbus 14
Manchester 14
Mexico City 14
Nairobi 14
Porto Alegre 14
Quito 14
Frankfurt am Main 13
Kochi 13
Totale 18.260
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 464
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 220
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 216
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 204
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 187
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 167
Activation of coaugulation and fibrinolysis in laparoscopic surgery 167
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 159
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 154
COVID-19 in Essential Thrombocythemia: Coagulopathy and Thrombosis 153
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 148
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 147
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 146
Activation of coagulation anf fibrinolysis in laparoscopic surgery 146
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 146
An unusual association between pancreatic cancer and Purtscher-like retinopathy: Presentation of a unique case 145
Activation coagulation and fibrinolysis in laparoscopic surgery 144
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 144
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 139
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 137
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 137
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 136
Acute myeloid leukemia in elderly patients. 134
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 133
A case of acute deterioration in asthma symptoms induced by isoniazid prophylaxis 131
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 130
A Large-Scale Trial Testing the Intensità of CYTOreductive Therapy to prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial). 129
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 129
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 127
Abnormality of the hemostatic status during stady-state phase in sickle cell/beta thalassemia. 127
Differences in diabetes treatment of the elderly depending on observation sites. 125
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 125
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 124
How to prevent intraoperative risks and complications in laparoscopic splenectomy 122
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 122
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 121
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 120
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 120
Alteration of endothelium-coagulative system during COPD exacerbations 120
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 119
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 119
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 117
European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) study: studio clinico controllato con aspirina a basse dosi per la prevenzione degli eventi trombotici nella policitemia vera. 116
. Comportamento dei livelli plasmatici della trombo- spondina e della trombomodulina nella talasso-drepanocitosi 113
Changes in sputum counts and airway responsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation 113
Endothelial activation and injury by cigarette smoke exposure 112
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 110
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 110
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 110
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 106
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 105
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 104
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 104
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 104
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 103
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 103
Lithium and acute myeloid leukemia. 103
Alpha in- terferon as first line therapy for angioimmunoblastic lymphoadeno- pathy. Prognostic role of activated T-lymphocities. 102
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 101
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 101
The Antiphospholipid Syndrome 100
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 99
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 99
Making, disseminating and using clinical guidelines 97
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 97
I disordini dell'emostasi nelle emopatie maligne. 96
Evidenza per una incrementata sintesi di fibronectina nell'endotelio vascolare di soggetti diabetici. 96
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 96
Aspirin-platelet sensotivity in patients with essentila thtombocythemia: role of betafibrinogen G-455-A gene polymorphism 96
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 96
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 95
Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbation 95
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 94
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 92
Factor-VIII-rela- ted antigen and vasculitis. 91
La splenectomia per via laparoscopica 91
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 91
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 90
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 90
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 89
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 89
Effects of anagrelide on platelet and fibrinolytic function in patients with essential thrombocythemia 89
Lom- Proteina C e potenziale fibrinolitico nel diabete mellitio di tipo II. 88
The antiphospholipid syndrome in pregnancy: a review article 88
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 88
OTTILIA and FORST : two international registries of foeto-maternal prognosis in women with recurrent reproductive failures after spontaneous or assisted conception 87
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 87
Adverse respiratory effects and allergic susceptibility in relation to particulate air pollution: flirting with disaster 87
Cardiovascular events and intensity of treatment in Polycythemia vera 87
Cutaneous vasculitis in non Hodgkin's Lymphoma. 86
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients 86
Thymostimulin in aplastic anaemia. 86
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 86
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 86
Interleukin-8 levels in patients with essential thrombocythemia. 85
Diabetes in the elderly: remarks from a epidemiological study carried out in a town of South-Eastern Sicily 84
Il significato diagno- stico e prognostico della fibronectina nel diabete mellito di tipo II. 84
Prothrombin concentration in patients heterozygous for the G20210 and Arg506Gln mutations 84
Endothelial-coagulative biomarkers in smoking cessation 84
Epidèmiologie de la thalassèmie dans la Sicile Orientale. 83
Totale 11.834
Categoria #
all - tutte 94.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 0 0 53
2021/20222.323 299 342 20 28 365 3 343 81 241 5 58 538
2022/20233.314 328 91 32 237 369 606 4 532 910 25 110 70
2023/20241.613 76 115 76 88 59 165 164 347 10 40 218 255
2024/20254.824 38 670 327 178 1.083 400 99 204 455 594 299 477
2025/202611.572 648 486 2.350 657 1.907 1.910 1.727 276 577 543 277 214
Totale 27.644